{"log_id": 8593400991765730766, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 3e-05, "average": 0.998027, "min": 0.965711}, "location": {"width": 828, "top": 166, "height": 37, "left": 194}, "words": "发性腹泻的危险。单药治疗时静脉滴注本品后发生首次稀便的中位时间是治疗后第5天。一"}, {"probability": {"variance": 1.2e-05, "average": 0.998764, "min": 0.979476}, "location": {"width": 805, "top": 215, "height": 34, "left": 197}, "words": "旦发生,患者应马上通知医生并立即开始适当的治疗。既往接受过腹部/盆腔放疗的患者"}, {"probability": {"variance": 0.000638, "average": 0.967793, "min": 0.942533}, "location": {"width": 49, "top": 210, "height": 29, "left": 1144}, "words": "药点"}, {"probability": {"variance": 8e-06, "average": 0.998353, "min": 0.987337}, "location": {"width": 825, "top": 261, "height": 38, "left": 197}, "words": "基础白细胞升高、一般状态评分≥2及女性患者,其腹泻的危险性增加。如治疗不当,尤其"}, {"probability": {"variance": 0, "average": 0.997863, "min": 0.997863}, "location": {"width": 46, "top": 247, "height": 31, "left": 1143}, "words": "准"}, {"probability": {"variance": 1e-06, "average": 0.999165, "min": 0.996846}, "location": {"width": 564, "top": 313, "height": 33, "left": 196}, "words": "是对于那些合并中性粒细胞减少症的患者,腹泻可能危及生命"}, {"probability": {"variance": 4.3e-05, "average": 0.997786, "min": 0.959814}, "location": {"width": 815, "top": 358, "height": 37, "left": 197}, "words": "一旦出现第一次稀便,患者需开始饮用大量含电解质的饮料并马上开始适当的抗腹泻治疗"}, {"probability": {"variance": 0.000128, "average": 0.997512, "min": 0.927409}, "location": {"width": 830, "top": 407, "height": 37, "left": 194}, "words": "这种抗腹泻治疗应由使用本品的单位来进行。出院的患者应携带特定的药物以便腹泻发生时"}, {"probability": {"variance": 2e-06, "average": 0.999143, "min": 0.991546}, "location": {"width": 725, "top": 457, "height": 35, "left": 196}, "words": "及时治疗。另外,当腹泻发生时,患者应将病情通报使用本品的医生及治疗单位"}, {"probability": {"variance": 0.001745, "average": 0.987919, "min": 0.723508}, "location": {"width": 827, "top": 504, "height": 36, "left": 198}, "words": "目前,推荐的抗腹泻治疗措施为:高剂量的氯苯哌酰胺(首次服药4mg,然后每2小时服药2mg)。"}, {"probability": {"variance": 0.000465, "average": 0.994331, "min": 0.864496}, "location": {"width": 830, "top": 552, "height": 36, "left": 196}, "words": "这种治疗需持续到最后一次稀便结束后12小时,中途不得更改剂量。本药有导致麻痹性肠梗"}, {"probability": {"variance": 0.00012, "average": 0.995962, "min": 0.941279}, "location": {"width": 814, "top": 601, "height": 34, "left": 198}, "words": "阻的危险,故所有患者以此剂量用药一方面不得少于12小时,但也不得连续用药超过48小时"}, {"probability": {"variance": 0.00087, "average": 0.989856, "min": 0.843248}, "location": {"width": 822, "top": 648, "height": 35, "left": 197}, "words": "除抗腹泻治疗外,当腹泻合并严重的中性粒细胞减少症(粒细胞计数<50/m3)时,应用"}, {"probability": {"variance": 3e-06, "average": 0.998616, "min": 0.99552}, "location": {"width": 193, "top": 703, "height": 26, "left": 194}, "words": "广谱抗菌素预防治疗"}, {"probability": {"variance": 1.5e-05, "average": 0.998523, "min": 0.980161}, "location": {"width": 525, "top": 747, "height": 32, "left": 196}, "words": "除用抗菌素治疗外,当出现以下症状时,应住院治疗腹泻"}, {"probability": {"variance": 0, "average": 0.999223, "min": 0.998486}, "location": {"width": 172, "top": 798, "height": 28, "left": 218}, "words": "腹泻同时伴有发热"}, {"probability": {"variance": 0.000106, "average": 0.994558, "min": 0.96613}, "location": {"width": 227, "top": 846, "height": 27, "left": 219}, "words": "严重腹泻(需静脉补液)"}, {"probability": {"variance": 1e-05, "average": 0.997796, "min": 0.989283}, "location": {"width": 502, "top": 891, "height": 30, "left": 219}, "words": "开始高剂量的氯苯哌酰胺治疗后腹泻仍持续48小时以上"}, {"probability": {"variance": 5.1e-05, "average": 0.996267, "min": 0.958224}, "location": {"width": 815, "top": 937, "height": 31, "left": 198}, "words": "氯苯哌酰胺一不应用于预防给药,即使前一治疗周期出现过迟发性腹泻的患者也不应如此"}, {"probability": {"variance": 3e-06, "average": 0.998929, "min": 0.991898}, "location": {"width": 460, "top": 987, "height": 29, "left": 198}, "words": "出现严重腹泻的患者,在下个治疗周期用药应减量"}, {"probability": {"variance": 0, "average": 0.999379, "min": 0.998629}, "location": {"width": 66, "top": 1040, "height": 26, "left": 198}, "words": "血液学"}, {"probability": {"variance": 0.00076, "average": 0.993817, "min": 0.823601}, "location": {"width": 825, "top": 1083, "height": 32, "left": 200}, "words": "在本品治疗期间,每周应监测全血细胞计数。患者应了解中性粒细胞减少症的危险性及发热"}, {"probability": {"variance": 0.009753, "average": 0.967619, "min": 0.458611}, "location": {"width": 824, "top": 1129, "height": 35, "left": 198}, "words": "的意义。发热性中性粒细胞减少症(T>38℃,中性粒细胞计数1,000/m3)应立即住院"}, {"probability": {"variance": 1e-06, "average": 0.99945, "min": 0.996789}, "location": {"width": 233, "top": 1184, "height": 26, "left": 198}, "words": "静脉滴注广谱抗菌素治疗"}, {"probability": {"variance": 1e-06, "average": 0.999407, "min": 0.996341}, "location": {"width": 563, "top": 1228, "height": 31, "left": 200}, "words": "曾发生严重血液学毒性的患者,建议在以后的治疗中降低剂量"}, {"probability": {"variance": 1.1e-05, "average": 0.998515, "min": 0.980703}, "location": {"width": 826, "top": 1277, "height": 30, "left": 200}, "words": "对出现严重腹泻的患者,其出现感染及血液学毒性的危险性会增加,因此应检查全血细胞计"}, {"probability": {"variance": 0, "average": 0.999867, "min": 0.999867}, "location": {"width": 25, "top": 1333, "height": 25, "left": 200}, "words": "数"}, {"probability": {"variance": 6.2e-05, "average": 0.993851, "min": 0.980503}, "location": {"width": 75, "top": 1381, "height": 27, "left": 200}, "words": "肝损害:"}, {"probability": {"variance": 1e-06, "average": 0.999466, "min": 0.996889}, "location": {"width": 383, "top": 1426, "height": 28, "left": 201}, "words": "治疗前及每个化疗周期前均应检查肝功能"}, {"probability": {"variance": 1.8e-05, "average": 0.99856, "min": 0.973401}, "location": {"width": 826, "top": 1473, "height": 28, "left": 202}, "words": "在高胆红素患者中,伊立替康清除率降低,因而其血液毒性增高。在此人群中应经常进行全"}, {"probability": {"variance": 0.000116, "average": 0.990269, "min": 0.97225}, "location": {"width": 105, "top": 1523, "height": 26, "left": 202}, "words": "血细胞计数"}, {"probability": {"variance": 1e-06, "average": 0.999332, "min": 0.997487}, "location": {"width": 434, "top": 1571, "height": 28, "left": 201}, "words": "本品不能用于胆红素超过正常值上限3倍的患者"}], "language": 3}